References
- Onnerhag K, Nilsson PM, Lindgren S. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD. Scand J Gastroenterol 2014;49:1111–18.
- LaBrecque D, Abbas Z, Anania F, Ferenci P, Ghafoor Khan A, Goh KL, et al. World gastroenterology organisation global guidelines, nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. June 2012. Available from www.worldgastroenterology.org/assets/export/userfiles/2012_NASH%20and%20NAFLD_Final_long.pdf. Accessed 25 September 2014.
- Festi D, Schiumerini R, Marzi L, Di Biase AR, Mandolesi D, Montrone L, et al. Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods. Aliment Pharmacol Ther 2013;37:392–400.
- Kayadibi H, Sertoglu E. Non-invasive indirect biochemical markers for liver fibrosis. Archiv Med Rev J 2014;23:427–42.